First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System (Antimicrobial Agents and Chemotherapy (2007) 51, 11, (4015-4021))

James S. Lewis; Monica Herrera; Brian Wickes; Jan E. Patterson; James H. Jorgensen

doi:10.1128/AAC.01501-07

First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System (Antimicrobial Agents and Chemotherapy (2007) 51, 11, (4015-4021))

James S. Lewis, Monica Herrera, Brian Wickes, Jan E. Patterson, James H. Jorgensen

Resultado de la investigación: Comment/debate › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	810
Número de páginas	1
Publicación	Antimicrobial agents and chemotherapy
Volumen	52
N.º	2
DOI	https://doi.org/10.1128/AAC.01501-07
Estado	Published - feb 2008

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)
Infectious Diseases

Acceder al documento

10.1128/AAC.01501-07

Otros archivos y enlaces

Citar esto

Lewis, J. S., Herrera, M., Wickes, B., Patterson, J. E., & Jorgensen, J. H. (2008). First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System (Antimicrobial Agents and Chemotherapy (2007) 51, 11, (4015-4021)). Antimicrobial agents and chemotherapy, 52(2), 810. https://doi.org/10.1128/AAC.01501-07

First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System (Antimicrobial Agents and Chemotherapy (2007) 51, 11, (4015-4021)). / Lewis, James S.; Herrera, Monica; Wickes, Brian et al.
En: Antimicrobial agents and chemotherapy, Vol. 52, N.º 2, 02.2008, p. 810.

Resultado de la investigación: Comment/debate › revisión exhaustiva

Lewis, JS, Herrera, M, Wickes, B, Patterson, JE & Jorgensen, JH 2008, 'First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System (Antimicrobial Agents and Chemotherapy (2007) 51, 11, (4015-4021))', Antimicrobial agents and chemotherapy, vol. 52, n.º 2, pp. 810. https://doi.org/10.1128/AAC.01501-07

@article{2510bd883f6449368f0e2f867a52b490,

title = "First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System (Antimicrobial Agents and Chemotherapy (2007) 51, 11, (4015-4021))",

author = "Lewis, {James S.} and Monica Herrera and Brian Wickes and Patterson, {Jan E.} and Jorgensen, {James H.}",

year = "2008",

month = feb,

doi = "10.1128/AAC.01501-07",

language = "English (US)",

volume = "52",

pages = "810",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "2",

}

TY - JOUR

T1 - First report of the emergence of CTX-M-type extended-spectrum β-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. Health Care System (Antimicrobial Agents and Chemotherapy (2007) 51, 11, (4015-4021))

AU - Lewis, James S.

AU - Herrera, Monica

AU - Wickes, Brian

AU - Patterson, Jan E.

AU - Jorgensen, James H.

PY - 2008/2

Y1 - 2008/2

UR - http://www.scopus.com/inward/record.url?scp=38649095624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38649095624&partnerID=8YFLogxK

U2 - 10.1128/AAC.01501-07

DO - 10.1128/AAC.01501-07

M3 - Comment/debate

AN - SCOPUS:38649095624

SN - 0066-4804

VL - 52

SP - 810

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 2

ER -